(Q37287556)

19 August 2017

1 reference

title

Breast cancer prevention in countries with diverse resources (English)

1 reference

19 August 2017

1 reference

John D Potter

3

0 references

Peggy L. Porter

series ordinal

2

object named as

Peggy Porter

1 reference

19 August 2017

1

Anne McTiernan

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

113

1 reference

19 August 2017

issue

8 Suppl

1 reference

19 August 2017

page(s)

2325-2330

1 reference

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23829

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23829

7 January 2021

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23829

7 January 2021

Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23829

7 January 2021

Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23829

7 January 2021

Physical activity and cancer risk: dose-response and cancer, all sites and site-specific

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23829

7 January 2021

Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23829

7 January 2021

Exercise and biomarkers for cancer prevention studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23829

7 January 2021

Mechanisms linking physical activity with cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23829

7 January 2021

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23829

7 January 2021

Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23829

7 January 2021

Dual effects of weight and weight gain on breast cancer risk

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23829

7 January 2021

Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23829

7 January 2021

Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23829

7 January 2021

Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23829

7 January 2021

Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23829

7 January 2021

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23829

7 January 2021

Oral contraceptive use and cancer. Findings in a large cohort study, 1968-2004

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23829

7 January 2021

BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23829

7 January 2021

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23829

7 January 2021

Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23829

7 January 2021

Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23829

7 January 2021

"Westernizing" women's risks? Breast cancer in lower-income countries

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23829

7 January 2021

Identifiers

DOI

10.1002/CNCR.23829

1 reference

19 August 2017

1 reference